Phase II study of monthly pasireotide LAR (SOM230C) for recurrent or progressive meningioma.
Times cited: 13
- A randomized, double-blind, placebo-controlled, phase 2 study of RMP-7 in combination with carboplatin administered intravenously for the treatment of recurrent malignant glioma. Neuro-Oncology. 2003 Academic Article GET IT